RxDoctor Payments Data

Mariam Benjamin, MD

Internal Medicine · Hilliard, OHNPI 1700954237

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.9% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by AbbVie at 53.9% of the total. That places this record below the midpoint for internal medicine clinicians in OH, where the typical reported total is $164.

$212in general payments, 2019–2025

Across 11 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$114
  • Exact Sciences$35
  • Novo Nordisk$18
  • GSK$17
  • Pfizer$15
  • Merck$13

What the payments were for

  • Food & beverage$19793%
  • Education$157%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)6$114
Exact Sciences1$35
Novo Nordisk1$18
GSK1$17
Pfizer1$15
Merck1$13

How this compares

$212 in reported general payments places this provider in the 50th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$100,187
Medicare patients
224
Services billed
3,050

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban83$92,084
JardianceEmpagliflozin55$60,167
OzempicSemaglutide29$44,791
XareltoRivaroxaban36$42,122
TrulicityDulaglutide22$29,910
FarxigaDapagliflozin Propanediol23$28,071
JanuviaSitagliptin Phosphate24$27,884
TradjentaLinagliptin17$23,694
MyrbetriqMirabegron19$13,354
SynthroidLevothyroxine Sodium84$7,351
Breo ElliptaFluticasone/Vilanterol11$6,257
Arnuity ElliptaFluticasone Furoate16$4,767
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$4,615
Bupropion XlBupropion Hcl141$3,332
Atorvastatin Calcium454$3,256

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$15$93,58598 claims
Novo NordiskOzempic$18$44,79129 claims
MerckJanuvia$13$27,88424 claims
GSKBreo Ellipta, Arnuity Ellipta$17$11,02427 claims
AbbVieSynthroid$114$7,35184 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Hilliard

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →